Randomized, double‐blind, placebo‐controlled trial of oral aloe vera gel for active ulcerative colitis

Abstract

Oral aloe vera taken for 4 weeks produced a clinical response more often than placebo; it also reduced the histological disease activity and appeared to be safe. Further evaluation of the therapeutic potential of aloe vera gel in inflammatory bowel disease is needed.